Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.8 |
mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | 0.0096 | 0.8 |
mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.8 |
mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.0089 | 0.8 |
mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.8 |
mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.8 |
mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | -0.0097 | 0.8 |